The leishmaniases. Report of a WHO expert committee. World Health Organ Tech Rep Ser1984: 701.
2.
Leishmaniasis identified in soldiers returning from Southwest Asia. Falls Church, VA: Office of the Surgeon General, 1991.
3.
HowardJGLiewFY. Mechanism of acquired immunity in leishmaniasis. Philos Trans R Soc Lond Biol1984; 307: 87–98.
4.
BadaróRCarvalhoEMRochaHQueirozACJonesTC. Leishmania donovani: An opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet1986; 1: 647–8.
5.
BerenguerJMorenoSCercenadoEde QuirósBernaldo JCLde la PuenteGarcía ABouzaE. Visceral leishmaniasis in patients with human immunodeficiency virus (HIV). Ann Intern Med1989; 111: 129–32.
6.
MartínezRGarcíaJDGutiérrezJRiopérezEValdiviesoLAlonsoF. Leishmaniasis visceral en pacientes adictos a drogas por vía parenteral, VIH positivos. Med Clin (Barc) 1987; 88: 509–11.
7.
SelimMMVlasinZZaroskovaL. Leishmaniasis—current recommended treatment. Int J Dermatol1990; 29: 318–21.
8.
MossJTWilsonJP. Current treatment recommendations for leishmaniasis. Ann Pharmacother1992; 26: 1452–5.
9.
BermanJDGallaleeJV. In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combination of antileishmanial agents. J Parasitol1987; 73: 671–3.
10.
BermanJDGoadLJBeachDHGolzGGJr. Effect of ketoconazole on sterol biosynthesis by Leishmania mexicana amastigotes in murine macrophage tumor cells. Mol Biochem Parasitol1986; 20: 85–92.